WHATNEXT partner website Patient Worthy recently published a conversation with cholangiocarcinoma patient Rick B. and his experience with hepatic artery infusion (HAI) treatment.
Author Jessica Lynn writes:
“The tumor had taken over 75-80% of his liver. Doctors predicted he had a few weeks, maybe a few months, left. Amidst the turmoil of what seemed like an irreversible fate, Rick’s narrative took an unexpected turn when physicians at Memorial Sloan Kettering Cancer Center (MSKCC) offered him a new form of therapy called hepatic artery infusion (HAI). “
Check out the full story here.
Editor’s Note: Get Involved
Cancer doesn’t discriminate. WHATNEXT and its partners are interested in amplifying the voices of those from all identities and backgrounds. If you have a cancer journey to share, reach out here to learn more about how your voice can help spread awareness and inspire individuals from all walks of life.
cholangiocarcinoma interview patient stories rare cancer
Last modified: August 5, 2024
